Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

NETZSCH Earns a Prestigious R&D 100 Award

Published: Tuesday, July 09, 2013
Last Updated: Tuesday, July 09, 2013
Bookmark and Share
New instrument is designed to test the performance and safety of Large Format Li-Ion Batteries.

NETZSCH Instruments North America, LLC (NETZSCH) has announced that the new Isothermal Battery Calorimeter IBC 284 284 developed based on National Renewable Energy Laboratory’s technology has been named among this year’s most significant innovations by R&D Magazine.

Known in the research and development community as “the Oscars of Innovation”, the R&D 100 Awards provide a mark of excellence known to industry, government, and academia as proof that the product is one of the most innovative ideas of the year.

The need for better performing and safer batteries created a market opportunity for instrumentation designers in battery development.

With this in mind, NETZSCH approached the Energy Department’s National Renewable Energy Laboratory (NREL), a leader in battery calorimetry technology, to develop a better way to detect heat loss in electric-vehicle batteries.

“With forecasts of more than half a million hybrid and electric cars this year - and with manufacturers needing to meet the regulated increased fuel efficiency - we saw a real gap in the marketplace for accurate testing of the larger battery systems” stated Dr. Gilles Widawski, President of NETZSCH Instruments North America, LLC.

Dr. Widawski continued, “The IBC 284 allows auto manufacturers to address safety and efficiency issues long before drivers have to rely on battery packs to get them back home. NREL has been working on battery thermal testing and calorimetry for over 15 years and the R&D Award is a fantastic recognition of their work.”

The new instrument is designed to test the performance and safety of Large Format Li-Ion Batteries used extensively in electric vehicles, airplanes, and military applications, as well as stationary power back-up and storage applications.

The instrumentation is able to safely and accurately characterize heat output and efficiency of the batteries under varying temperature, pressure, load and use conditions, providing precise and critical information previously unavailable.

Temperature has a strong impact on the performance, safety, and life of batteries. Temperature control is necessary to successfully operate lithium ion batteries, particularly for electric drive vehicles, which will play a critical role in lowering dependence on imported oil and air pollution.

The IBC’s patent-pending innovations-complete thermal isolation, the ability to test large cells and batteries, and the features needed to test high energetic batteries safely-provide a level of accuracy and functionality not seen in other calorimeters.

The ability to precisely measure heat generation helps to optimize battery thermal-management systems and to both extend battery life and improve safety at an affordable cost.

The NETZSCH team included Peter Ralbovsky, Jean-Francois Mauger, and Gilles Widawski. NREL’s Isothermal Battery Calorimeters team included Matt Keyser, Ahmad Pesaran, John Ireland, Dirk Long, and Mark Mihalic.

51st Year of Awards for Innovation
Since 1963, the R&D 100 Awards have identified revolutionary technologies newly introduced to the market. Many of these have become household names, helping shape everyday lives.

Winners of the R&D 100 Awards are selected by an independent judging panel and the editors of R&D Magazine. The publication and its online portal serve research scientists, engineers, and other technical staff members at high-tech industrial companies and public and private laboratories around the world.

Winners will be recognized at the R&D 100 Awards Ceremony to be held in Orlando on Nov. 7, 2013. A full list of this year’s winners is available at

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Refining DSC Curves
Differential Scanning Calorimetry (DSC) is a method which determines the difference in heat flow between a sample and a reference. A closer look at the resulting curve, however, makes it clear that the temperature behavior and peak characteristics shown are not a true reflection of the sample behavior. In order to correct this distortion, NETZSCH has developed the “Tau-R Mode”.
Thursday, November 04, 2010
NETZSCH invests € 1.8 M into its Selb location
The groundbreaking for the construction of a new annex on May 28 marks the opening of a new chapter in NETZSCH-Gerätebau’s almost 50-year history.
Thursday, July 01, 2010
Engineering Safety into Highly Critical Components
Thermal conductivity and diffusivity are thermophysical material parameters necessary for describing the heat transport properties of a material or component. These physical parameters are the basis for accurate thermotechnical simulations or for the analysis of temperature fields in components for electronic assemblies, power plant turbines or drive units.
Thursday, March 25, 2010
New Management Team at NETZSCH-Geratebau GmbH
Dr. Otto Max Schaefer has resigned from his interim task as Managing Director and has now turned his full concentration in the management.
Wednesday, July 23, 2008
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos